Browse the evidence

Lifestyle interventions (diet, exercise, or behavioral) significantly improve anthropometric, metabolic, and reproductive markers in women with PCOS, specifically reducing body weight, waist circumference, fasting insulin, and testosterone levels.

For women with PCOS, engaging in structured lifestyle changes—whether through diet, exercise, or behavioral counseling—can significantly improve key health markers. Specifically, these interventions can lead to modest but meaningful reductions in body weight, waist circumference, and insulin levels, as well as improvements in testosterone levels and hirsutism. While lifestyle changes did not show significant effects on glucose tolerance or lipid profiles in this review, they remain a first-line recommendation for managing the underlying hormonal and metabolic disturbances of PCOS.

Sustained nutritional ketosis achieved through a continuous remote care intervention (CCI) involving carbohydrate restriction (<30g/day initially) leads to significant improvements in glycemic control, weight loss, and diabetes remission in Type 2 Diabetes patients over 2 years, while reducing medication dependence without adverse effects on bone health.

To manage Type 2 Diabetes long-term, consider a continuous care approach that includes nutritional ketosis. Start with less than 30g of carbs per day, aiming for a blood ketone level of 0.5-3.0 mmol/L. Work with a healthcare team to monitor your progress and adjust medications as needed. This approach has been shown to improve blood sugar, reduce weight, and even reverse diabetes in many cases over 2 years, without harming bone health.

High-intensity progressive resistance training (20 weeks, 2x/week) significantly improves muscle strength, functional performance, and balance in older men receiving androgen deprivation therapy (ADT) for prostate cancer, while preserving lean mass and bone mineral density.

If you are undergoing hormone therapy for prostate cancer, do not avoid exercise. A structured resistance training program (lifting weights 2 times a week, focusing on 6-12 reps per set) is safe and highly effective. It will not interfere with your cancer treatment (PSA/testosterone levels remain stable) and will significantly improve your muscle strength, balance, and ability to perform daily activities, while preventing the muscle and bone loss typically caused by the therapy.

Regular physical exercise is the most effective non-pharmacological intervention for preventing and treating age-associated skeletal muscle changes (sarcopenia) by modulating anabolic/catabolic pathways and reducing oxidative stress.

To combat age-related muscle loss, engage in regular exercise combining aerobic activity (50-80% of your max heart rate, 2-3 times a week) and resistance training (50-80% of your one-rep max, 2 days a week). This approach is the most effective way to maintain muscle mass, strength, and functional capacity in older age.

A 12-week ketogenic Mediterranean diet (KEMEPHY) significantly improves metabolic and hormonal markers in overweight women with PCOS, including reductions in body weight, fat mass, insulin resistance, and androgens, alongside improvements in lipid profiles and sex hormone binding globulin.

For overweight women with PCOS, a 12-week ketogenic Mediterranean diet (approx. 1600-1700 kcal, <30g carbs) significantly reduces weight, fat mass, and insulin resistance while improving hormonal balance (lower testosterone, higher SHBG). This approach addresses the root hormonal drivers of PCOS more effectively than standard caloric restriction alone, though it requires strict adherence and medical supervision due to the small sample size of supporting evidence.

Moderate-intensity aerobic or resistance exercise improves insulin resistance and ovulation rates in women with PCOS, independent of significant weight loss.

For women with PCOS, engaging in moderate-intensity exercise (like brisk walking or cycling) 3-5 times a week for 30-45 minutes can significantly improve insulin sensitivity and restore regular ovulation. This benefit occurs regardless of whether you lose weight, so consistency is more important than intensity or weight loss goals.

In professional athletes with vitamin D insufficiency during winter months, supplementation with 5000 IU/day of vitamin D3 for 8 weeks significantly improves vertical jump height and 10-meter sprint times.

If you are a competitive athlete training in a northern climate during winter, get your Vitamin D levels checked. If you are deficient, taking 5000 IU of Vitamin D3 daily for 8 weeks can significantly improve your sprint speed and jumping power. This is not just about bone health; it directly impacts performance metrics like vertical jump and 10m sprint times.

Beetroot juice supplementation improves cardiorespiratory endurance in athletes by increasing nitric oxide bioavailability, which enhances blood flow, mitochondrial efficiency, and exercise economy, particularly in normoxic conditions.

If you are a trained endurance athlete, consuming beetroot juice providing 5-8 mmol of nitrate 2-3 hours before exercise may improve your efficiency and time to exhaustion, particularly in normal oxygen conditions. However, do not expect guaranteed results, especially if you are training at high altitude or consuming caffeine simultaneously, as these factors may negate the benefits.

A functional foods-based diet, emphasizing whole grains, legumes, nuts, and phytochemical-rich fruits and vegetables, improves glycemic control, insulin sensitivity, and lipid profiles in type 2 diabetes management.

Replace refined grains with whole grains (oats, barley, rye), include legumes (lentils, beans) and nuts in your daily diet, and eat a variety of colorful fruits and vegetables. This approach helps manage blood sugar and cholesterol more effectively than standard dietary advice alone.

Vitamin D deficiency (serum 25(OH)D < 20 ng/mL) is causally linked to musculoskeletal pain, muscle atrophy (specifically type II fibers), and increased fall risk in the elderly, while supplementation to levels >30 ng/mL can alleviate pain and improve muscle performance.

If you are over 50 or suffer from unexplained muscle pain or frequent falls, ask your doctor to check your Vitamin D levels (25(OH)D). If they are below 30 ng/mL, supplementation (typically 700-1000 IU/day) is likely to help with muscle strength and fall prevention. Do not assume high doses are better; excessive dosing may actually increase fall risk.

Combining low-intensity resistance exercise (10-20% 1RM) with moderate vascular occlusion (tourniquet pressure ~218 mmHg) induces significant muscular hypertrophy and strength gains, whereas performing either the exercise or the occlusion alone does not.

To build muscle with light weights, perform low-intensity resistance exercises (10-20% of your one-rep max) while applying moderate vascular occlusion to your thighs using a tourniquet. Do 5 sets of 15-20 reps, twice a week, for 8 weeks. Release the tourniquet immediately after each session. This combination is necessary; neither light exercise nor occlusion alone will produce significant muscle growth.

Higher consumption of whole grains is inversely associated with body weight, BMI, and obesity biomarkers (insulin, C-peptide, leptin) compared to refined grains, primarily through mechanisms involving lower glycemic index, increased satiety from fiber, and improved insulin sensitivity.

To support healthy weight, prioritize whole grain foods like whole-grain bread, cereals, brown rice, and oats over refined grains. This shift helps manage blood sugar and insulin levels, which are key drivers of fat storage and hunger. Aim to replace at least some refined grain servings with whole grain options daily.

Younger individuals (≤50 years) experience more significant weight and waist circumference reductions from Survodutide compared to older individuals (>50 years).

If you are 50 years or younger, you may experience greater weight loss from Survodutide than those over 50. This is likely due to metabolic differences and fewer comorbidities in younger patients, but the drug remains effective across age groups.

Expanding access to GLP-1 and GIP/GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) for eligible populations in the US could avert approximately 43,719 deaths annually by reducing obesity-related mortality.

If you have a BMI of 30 or higher (or 27+ with conditions like diabetes), you are likely eligible for GLP-1 medications like semaglutide or tirzepatide. These drugs are highly effective for weight loss and can significantly reduce your risk of early death from obesity-related causes. The main barrier is not efficacy, but cost and insurance coverage. Discuss these options with your doctor and explore insurance coverage options or patient assistance programs, as expanded access policies may soon make these treatments more available and affordable.

Tirzepatide is the only obesity management medication shown to significantly reduce the Apnea-Hypopnea Index (AHI) and achieve remission of Obstructive Sleep Apnea Syndrome (OSAS) in patients with obesity.

If you have obesity and sleep apnea, Tirzepatide has been shown to significantly reduce the severity of your sleep apnea (AHI) and can lead to remission of the condition. This is a unique benefit not clearly demonstrated by other weight loss drugs in this review.

Weight loss efficacy from primary care interventions attenuates over time, with an average regain of 0.53 kg per 6 months, even when the intervention continues.

Don't expect your weight loss to stay perfectly static. Even with ongoing treatment, you may regain about 0.5 kg every 6 months. This is normal. To maintain your loss, you likely need to stay on your treatment plan (including medication if used) long-term, rather than treating it as a short-term fix.

Anti-obesity medication (AOM) administered in primary care settings produces approximately double the weight loss (-2.94 kg) compared to non-pharmacologic interventions, but efficacy attenuates over time at a rate of 0.44 kg per six months.

If you are seeking weight loss in primary care, expect that adding medication to lifestyle changes will roughly double your weight loss compared to lifestyle changes alone. However, be prepared for this to be a long-term commitment; stopping the medication often leads to regaining the weight because your body fights to maintain the lower weight. Consistency and long-term use are key to maintaining results.

Omega-3 fatty acid (n-3 PUFAs) supplementation augments muscle protein synthesis (MPS) and mTOR signaling in the elderly, potentially by attenuating age-related anabolic resistance through anti-inflammatory mechanisms.

Consider adding omega-3 supplements (fish oil) to your diet. While they won't build muscle on their own, they may help your body respond better to protein and exercise, especially if you have chronic inflammation.

Low-Carbohydrate diets are more effective in reducing HbA1c in the short term (<12 months), in smaller studies, and in patients aged 60 years or older.

If you are over 60 years old with Type 2 Diabetes, a Low-Carbohydrate diet may offer superior HbA1c reduction compared to other diets, especially if you can maintain it for less than a year. This subgroup benefit was not as pronounced in younger or longer-term studies.

Omega-3 fatty acid supplementation attenuates muscle loss and accelerates recovery during periods of muscle disuse (immobilization) in young women.

If you are a young woman facing temporary immobilization (e.g., injury/surgery), taking ~3g EPA and ~2g DHA daily before and during the immobilization period may help preserve muscle volume and speed up recovery compared to not taking omega-3s.

In this urban Tanzanian population, higher BMI and waist circumference are significantly correlated with adverse lipid profiles and blood pressure in men, but this association is significantly weaker or absent in women.

For men in this population, managing weight is directly linked to managing blood pressure and cholesterol. For women, while weight management is still important for metabolic syndrome, the direct link between weight and blood pressure/lipids is less predictable, suggesting that regular metabolic screening is crucial regardless of BMI.

Omega-3 fatty acid supplementation (4g/day) enhances the sensitivity of skeletal muscle to amino acids and insulin, increasing MPS and mTOR activation in young and elderly subjects.

Consider taking 4g of omega-3 fatty acids daily. Recent research suggests this may help your muscles respond better to protein and exercise, potentially aiding muscle growth in both young and old.

Obesity exacerbates age-related anabolic resistance, leading to impaired muscle protein synthesis (MPS) response to nutrition and exercise, resulting in poor muscle quality despite preserved mass.

If you are older and obese, your muscles may not respond to protein and exercise as well as a younger or leaner person's. This is called 'anabolic resistance.' It means you might need to pay extra attention to protein intake and resistance training to maintain muscle quality, even if your muscle mass looks okay. Don't give up if progress feels slow; it's a biological hurdle, not a personal one.

Adjunct treatment with once-weekly semaglutide (max 0.5 mg) induces significant weight loss in non-diabetic patients experiencing weight regain or insufficient weight loss after bariatric surgery.

If you have had bariatric surgery and are regaining weight or haven't lost enough, talk to your doctor about adding once-weekly semaglutide. This study shows it can help you lose significant weight (over 10% in 6 months) even at a lower dose (0.5 mg) than what is typically used for non-surgical obesity. It is a safe adjunct to lifestyle changes and may help you avoid more invasive revision surgery.